Ryan Jacobs

Ryan Jacobs joined the Levine Cancer Institute (LCI) in Charlotte, NC in 2015 where he has served as a CLL and lymphoma specialist since that time. He functions as a principle investigator on numerous clinical trials and now serves as the clinical director of the lymphoma division.

Dr. Jacobs has both a clinical and research focus in patients with Chronic Lymphocytic Leukemia (CLL). In his role as a principal investigator, he oversees the clinical trials conducted at Levine Cancer Institute that involve the treatment of patients with CLL. As the CLL expert for the LCI/Atrium Health system, Dr. Jacobs is responsible for creating and overseeing the patient care pathways involving the treatment of CLL patients in the Atrium Health/LCI network that spans North Carolina, South Carolina, and Goergia. In addition to clinical trials.

Dr. Jacobs also has a research interest in real world outcomes of patients with CLL on novel therapies and has contributed to this field of research by utilizing the large LCI network and evaluating patients across LCI imprint treated in a variety of clinical settings. Dr. Jacobs graduated from Baylor College of Medicine in Houston, TX in 2009. He then completed his internship and residency in internal medicine at Vanderbilt University in Nashville, TN in 2012. Dr. Jacobs returned to Houston and completed his training with his hematology/oncology fellowship at MD Anderson Cancer Center in 2015.